By use of a computer-generated randomisation sequence , we randomly allocated patients ( @:@:@:@ ; block size of six ; no stratification ) to drisapersen @ mg/kg or placebo , each given subcutaneously and either continuously ( once weekly ) or intermittently ( nine doses over @ weeks ) .